Article Information
History
- Received May 28, 2022
- Revision received July 7, 2022
- Accepted July 10, 2022
- Published online September 14, 2022.
Copyright & Usage
© 2022 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
Author Information
- Masataka Wada, MD,
- Shinichiro Nakajima, MD, PhD,
- Shiori Honda, MSc,
- Mayuko Takano, MSc,
- Keita Taniguchi, BSc,
- Sakiko Tsugawa, MD,
- Yu Mimura, MD,
- Nanao Hattori,
- Shinsuke Koike, MD, PhD,
- Reza Zomorrodi, PhD,
- Daniel M. Blumberger, MD, MSc,
- Zafiris J. Daskalakis, MD, PhD,
- Masaru Mimura, MD, PhD,
- Yoshihiro Noda, MD, PhD, MBA
- From the Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan (Wada, Nakajima, Honda, Takano, Taniguchi, Tsugawa, Y. Mimura, Hattori, M. Mimura, Noda); the Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Nakajima); Teijin Pharma Ltd., Tokyo, Japan (Takano); the Center for Evolutionary Cognitive Sciences, Graduate School of Art and Sciences, University of Tokyo, Tokyo, Japan (Koike); the Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ont. (Zomorrodi, Blumberger); the Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ont. (Zomorrodi, Blumberger); the Department of Psychiatry, Faculty of Health, University of California San Diego, San Diego, CA (Daskalakis)
- Correspondence to: Y. Noda and S. Nakajima, Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan; yoshi-tms{at}keio.jp, shinichiro_nakajima{at}hotmail.com